Skip to main content

Chain Drugstore Daily @ NACDS AM • April 21, 2026

Page 1


CHAIN DRUGSTORE Daily

Suave New High-Performance Haircare for Less Than $5

MEDITERRANEAN BALLROOM #48

As the industry looks toward the 2026 beauty landscape, Suave remains committed to removing the

How Liquid AI is Rewriting the Rules of Retail Decision-Making

Sally Hansen’s Fan Favorite Gets an Upgrade

Chain drugstores face a massive challenge: Too much data and too little time You track everything from front-end consumer p a c

x pharmacy metrics. Yet, when you need quick answers to drive growth, that data often sits trapped behind complex dashboards or a small team of overloaded analytical experts Circana is changing how you interact with your

You are undoubtedly familiar with this famous quote: “The definition of insanity is doing the same thing over and over and expecting different results

onates with our own pharmacy industry because it’s such a good metaphor for the one-sided rela-

Dulcolax Expands in the World of Gut Wellness

For decades, Dulcolax has been a leader in constipation relief as the No. 1 laxative brand in the world. Now, Dulcolax is expanding its commitment to digestive health by addressing a growing consumer need: gut support with the launch of Dulcolax Daily Gut Support* Gummies The brand is expanding beyond episodic problem-solver to a proactive partner for everyday gut support

Sally Hansen is the OG nail category innovator, trusted for decades for delivering salon-quality nail color and care solutions for at-home use, continuing to evolve the at-home beauty landscape The brand assortment includes more than just nail polish; there’s so much more to explore, including cuticle removers and oils, press-ons, leg makeup, nail art tool kits and more DIY nails have never been easier (or

PBM Reform Raises the Bar for Pharmacy Benefit

Rivera, an independent pharmacy payment integrity company, published a new issue brief examining why the current wave of PBM reform raises the bar for pharmacy benefit oversight without replacing the need for it

Recent federal and state actions have increased s c r u t i n y o f how pharmacy b

a d m i n i s

d , including changes tied to Medicare Part D, ERISA disclosure expectations and broader oversight of PBM

whether new contract terms, pricing structures and MEZZANINE

M&M’S Pops with Brand’s First-Ever

Freeze-Dried Candy, M&M’S POP’d Caramel

M&M’S®, part of Mars, announced its

l a t e s t i n n o v a t i o n , M & M ’ S POP’d, the brand’s first-ever

f r e e z e - d r i e d c a n d y , o ing a totally new, tot irresistible and poppa snacking experience

N e w M & M ’ S P O P

C

fans love in an unex

p e c t e d l y l i g h t , c r i s p y and crunchy new tex-

t u r e – n e v e r b e f o r e seen from M&M’S

“ W i t h M & M ’ S

POP’d Caramel, we’re giving fans a whole

n e w w a y t o e n j o y the classic caramel flav been a fan-favorite in our lineup for y e a

d M

expected to grow to almost $2 4 billion by 2030, close to double its current

, V

c e President of Marketing, Mars Wrigley North America “This fresh and fun new treat takes everything you love about M & M ’ S a n d g i v e s i t a l i g h t , c r i s p y crunch, bringing the flavors and textures together in an unexpected new way ” The freeze-dried candy market is

with SKITTLES®

TikTok in 2024,

eight days

On the heels

&M’S new freeze-

e for bold, exciting and novelty textures and treats M&M’S POP’d Caramel makes it the perfect poppable treat to make sharing a FUN new taste experie

little sweeter – because “It’s More Fun Together.”

M & M ’

Continued on Page 29

AOM Infusion Selected as a Limited Distribution Specialty Pharmacy for QIVIGY

AOM Infusion (“AOM”), a leading specialty infusion pharmacy and provider, a n n o u n c e d

d r i o n

Biopharma’s limited distribution network for QIVIGY®, a new 10% immune globulin (Ig) liquid indicated for treatment of adults with Primary Humoral Immunodeficiency (PI)

The addition of QIVIGY expands AOM’s immune globulin portfolio and strengthens its ability to help patients and providers access innovative therapies for complex immune disorders. This announcement builds on AOM’s recent collaboration with Kedrion for YIMMUGO®, a 10% immune globulin liquid also indicated for the treatment of PI

Continued on Page 29

Blink: The Fastest Growing Dry Eye Brand Is Powering the Category’s Next Wave of Innovation

Dry eye symptoms continue to rise across the United States as the popula-

modern demands reduce how often

people blink, creating a strong need for science backed products that offer lasting dry eye symptom relief

T

d

American adults experience dry eye symptoms, yet only about one-third treat them with OTC products, leaving a l a r

n g m a j o r O T C

y e y e brand in the United States, Bausch + Lomb Blink® has been helping to meet that need with its differentiated formulas and its focus on the modern causes of dry eye symptoms

“ C o n s u m e r s o f t e n t u r n t o O T C options as a first line of treatment, but they are looking for more than just symptom relief They want products that fit seamlessly into their lives,” said

J o h n F e r r i s , P r e s i d e n t , C o n s u m e r , Bausch + Lomb “Blink is specifically formulated for today’s on-the-go consumers who balance work and play in today’s digital environment.”

The Blink portfolio includes Blink Triple Care, the first over-the-counter eye drop to combine hyaluronate and nano emulsion lipids This clinically proven product relieves dry eyes and locks in moisture for instant, long-lasting relief Bausch + Lomb is further expanding the

portfolio this year with Blink Triple Care Preservative Free As more consumers seek preservative-free options, Blink Triple Care Preservative Free gives them another choice within the brand’s growing dry eye portfolio This new formulation delivers the same dual action benefits in a preservative free format for those who prefer it.

further improve the

ence A next generation bottle technolo-

aims to improve eye d r o p a c c u

help users overcome

reflex

an issue for

e drop users. The techn

g y c o u l d b e applied across all Blink products and other Bausch + Lomb eye drop brands

These innovations, combined with a m o d e

g strategy, continue to drive the Blink b r a n d ’ s m o m e n t u m T h e a p p r o a c h blends clinical credibility with strong digital reach and highlights real life moments – whether at work, gaming, traveling or at home – when dry eye symptoms disrupt comfort or productivity, reinforcing Blink as the eye drop brand that keeps consumers feeling and performing their best

Direct engagement with eye care professionals is also a key part of the strategy. The company provides clinicians with education, clinical resources, sampling and in-office tools to help guide patients to the Blink formulation that best meets their needs

“While the need for dry eye relief continues to rise, so do the expectations consumers bring to this category,” Ferris continued. “We’re committed to delivering innovations that not only meet those expectations but redefine what consumers can expect from their everyday eye care ”

F o r m o r e i n f o r m a t i o n , g o t o w w w justblink com or stop by Space #519

RIS Rx Introduces New Brand

RIS Rx announced a new brand identity and messaging platform reflecting its expanding role in addressing one of

Advancing Insulin Injection with Contoured Base Pen Needles

Consistent insulin delivery is an essential component of effective diabetes management, yet many patients face challenges that can compromise the quality and efficacy of their injection therapy routine Injection technique, force and needle design all play an important role in whether insulin is consistently delivered to the subcutaneous fat, where it is most effective in controlling glucose levels Fortunately, pen needle design can help address some common injection errors to support better patient outcomes.

F o r e x a m p l e , e m b e c t a ’ s N a n o ™

2nd Gen Pen Needles were developed to help patients deliver insulin more consistently by improving how force is d i s t r i b u t e d a t t h e i n j e c t i o n s i t e Traditional pen needles have a posted base, while Nano 2nd Gen is currently the only pen needle with a contoured base, a feature designed to compensate for excessive injection force By d i s t r i b u t i n g p r e s s u r e m o r e e v e n l y across the skin surface, this contoured base supports a more consistent 4mm target injection depth as recommended by experts.1

T h i s d e s i g n a d v a n c e m e n t h a s meaningful clinical implications Nano 2nd Gen Pen Needles are estimated to reduce the risk of intramuscular injections by two- to eight-fold compared with 4mm posted base pen needles 2 This is critical, as intramuscular inject i o n s h a v e b e e n a s s o c i a t e d w i t h a greater risk of hypoglycemia due to unpredictable insulin absorption 3 With

enue leakage

The refreshed brand centers on a discipline RIS Rx helped pioneer – realtime GTN Revenue Protection – which focuses on identifying and preventing GTN revenue leakage before it occurs

consistent injection into the subcutaneous tissue, patients are less likely to experience bruising and pain, which can come from unintended intramuscular delivery

T h e i m p o r t a n c e o f p e n n e e d l e design was recently reinforced when u p d a t e d g l o b a l b e s t p r a c t i c e s f o r insulin injection technique – known as FITTER Forward – were published in Mayo Clinic Proceedings in April 2025

T h e s e r e c o m m e n d a t i o n s e m p h a s i z e the role of advanced pen needle features alongside proper injection education. Specifically, experts recommend using a 4mm x 32G pen needle that incorporates a contoured needle base, a 5-bevel tip and ultra-thin wall technology – all features uniquely combined in Nano 2nd Gen Pen Needles As the only pen needles aligned to t h e n e w e x p e r t r e c o m m e n d a t i o n s , pharmacists may wish to suggest Nano 2nd Gen Pen Needles as one way to help improve their patients’ comfort, consistency and safety during insulin injections

F o r m o r e i n f o r m a t i o n , g o t o w w w embecta com or stop by Space #456

1 Klonoff DC, Berard L, Franco DR, et al Advance Insulin Injection Technique and Education with FITTER Forward Expert Recommendations Mayo Clin Proc 2025; 100(4):682-699

2 Rini C, Roberts BC, Morel D, et al Evaluating the impact of human factors and pen needle design on i n s u l i n p e n i n j e c t i o n J D i a b e t e s S c i T

2019;13(3):533-545

3 Frid AH, Kreugel G, Grassi G, et al. New insulin d e

2016;91(9):1231-1255

ers, the Gross-to-Net spread represents one of the largest and least transparent components of the income statement.

RoC Skincare Introduces Revolutionary Derm Correxion Lip Volumizer

R o C S k i n c a r e , a l e a d e r i n c l i n i c a l l y proven skincare solutions backed by more than 150 clinical studies and 30 y e a r s o f s k i n h e a l t h r e s e a r c h , announced the launch of its ground-

b r e a k i n g D e r m

C o r r e x i o n ® L i p

V o l u m i z e r T h i s non-invasive topical lip treatment, developed in col-

l a b o r a t i o n w i t h

d e r m a t o l o g i s t s

a n d p l a s t i c s u r -

g e o n s , p r o v i d e s instant and long-

t e r m p l u m p i n g effects inspired by l i p i n j e c t i o n s , w i t h o u t t h e n e edles.

“ W e a r e thrilled to make our debut in the lip care market,” says Art Pellegrino, Chief Scientific Officer at RoC Skincare “Our n e w D e r m C o r r e x i o n L i p V o l u m i z e r isn’t just another lip gloss; it’s the culmination of years of research dedicated to understanding the unique needs of lips’ delicate skin. With this product, w e ’ v e h a r n

advanced ingredients to create a topical alternative to injectables, offering consumers a safe and effective way to

both immediately and over time We’re confident this launch will

are filling ingredients, including 10% Hyaluronic Acid Filling Spheres that instantly volumize lips and hydrate for up to 48 hours Additionally, a powerful Pro-Collagen Peptide actively smooths and redefines lip contours for a more youthful appearance. In a clinical study, 90% of participants saw fuller, plumper lips in just three minutes, with a 2X improvement in visible volume over four weeks

Key Benefits

• Instant plumping: See visibly fuller lips in just three minutes.

• Long-lasting hydration: Provides deep hydration for up to 48 hours

to achieving fuller lips,

injectables,” says Dr Melissa K Levin, RoC

Dermatologist. “RoC’s

Volumizer offers a breakthrough, needle-free solution that visibly plumps and hydrates while addressing the nine key signs of lip aging – delivering a

tion ”

Of the ingredients in the Derm Correxion Lip Volumizer formula, 25%

The Emerson Group: Powering Health, Wellness & Beauty Brands Across North America

Since 1994, The Emerson Group has been the trusted partner to brands,

C P G Industry Its people are CPG professionals and omni-channel commerce experts

The Emerson Group has built a fully integrated infrastructure and suite of capabilities focused on launching and accelerating the growth of health,

• Y o u t h f u l a p p e a r a n c e : S m o o t h s and redefines lip contours while restoring the lips’ natural color

• Non-invasive: A topical alternative to lip injections In one week, 87% would use it instead of lip injectables

• Dermatologist tested: Suitable for all skin types.

The formula is non-sticky and glides smoothly directly onto lips from its precision cooling tip It can be applied throughout the day onto bare lips or over lip color, and may produce a slight tingling sensation upon application, which signals that it is working.

Derm Correxion Lip Volumizer is a

wellness and beauty brands. T h e p

etary OMEGA data t

brand insights and d

l y t i c s t o create the brand’s go-to-market strategy, omnichannel distribution, marketing plans and supply chain.

www rocskincare com

About RoC Skincare RoC Skincare has been revolutionizing skincare science since 1957 when Dr Jean-Charles Lissarrague, a French pharmacist at the Rogé Cavaillès pharmacy, created the first hypoallergenic skincare formulations RoC has continued to build on its legacy as a brand of firsts, launching the first broad-spectrum UV protection to proactively preserve the health of skin, and the first brand to discover the method for stabilizing Retinol Collaborating closely with Dermatologists, RoC scientists have spent over 67 years garnering a deep understanding of skin physiology at the cellular level Today, RoC is at the forefront of dermatological innovation, harnessing cutting-edge technology to achieve over 35 patented breakthroughs in retinol, vitamin C, hyaluronic acid and pro collagen amino acids. With over 150 clinical studies, every RoC formula undergoes rigorous clinical testing to prove its high efficacy without any compromises on safety RoC is 100% hypoallergenic,100% non-comedogenic, PETAapproved and always clinically proven

Cabana #15

.emersongroup.com.

The infra-

partners in the United States, C

Mexico

For more infor-

Sally Hansen’s Fan-Favorite Insta-Dri Collection

Sally Hansen Insta-Dri® Nail Color is the No. 1 Fast-Dry Polish in the United States. Insa-Dri’s 3-in-1 formula features a built-in base and topcoat to offer the ultimate shiny, extended wear in a single step and the u n i q u e , c o n t o u r e d brush allows for a perfect application

S a l l y H a n s e n ’ s Insta-Dri has been recognized by Allure’s Best of Beauty Awards as one o f t h e b e s t q u i c k - d r y formulas on the market

f o r t w o c o n s e c u t i v e years (2024 and 2025), a true testament to North America’s No. 1 quickdry formula The awardw i n n i n g , I n s t a - D r

mula dries in 60 seconds – S t r o k e O n e c o a t

D o n e N o w a i t N o smudge

matte Flower Powder pastels collection of eight shades. This collection features soft seasonal shades in a satin matte finish – airy, modern and effortlessly chic Get your perfect spring mani in a

The No. 1 quick-dry nail polish in the United States, Sally Hansen’s Insta-Dri continues to provide bold color and transformative effects in finishes that move at your speed, transforming your manicure with just one stroke Available in classic, trendy and a variety of finishes, level up your mani from shimmering iridescence to mermaid-like glitter.

Sally Hansen expands its collection with three new limited-edition collections: Flower Powder, Electric Feels and S m o o t h i e S a l l y H a n s e n I n s t a - D r i Electric Feels Collection is a bold, eight shade fast-drying collection that delivers vibrant colors in a flash Step into spring with Sally Hansen’s new satin-

shades that are blended to perfection with juicy shades that are icy, sweet, playful and full of flavor One coat is an instant mood boost

Sally Hansen’s Insta-Dri is a bestseller and fan-favorite, including NBA p

Rock The brand has partnered with both on content showcasing the creators’ favorite shades and testing wear and application techniques

For more information, go to www sally hansen.com or stop by Mezzanine #15.

Method Super Shine Cuts Through Grease & Grime with Less Scrubbing

Method super shine, a new enzymepowered line of dish soaps designed to cut through grease and grime with less scrubbing, launched early 2026 The range includes liquid dish soap, foaming spray and refill formats Bringing t h e c u t t i n g - e d g e t e c h n o l o g y o f enzymes to the dish soap aisle, method is introducing a new way to tackle the dishes – one that targets tough stains from starches, fats and proteins for a more effective clean that transforms a daily chore into an enjoyable everyday ritual

At the core of the award-winning formula is a powerful blend of amylase and protease The formula removes up to 99% of grease with significantly less s c r u b b i n g ( v e r s u s o r i g i

dish soap), creating a smoother, quicker dish-washing experience The foam-

enzyme, lipase, to cut through fats like butter, oil and grease Its self-foami

wide-spray coverage, effortlessly coating dishes for a faster way to clean dishes. M e t h o d s u p e r s h i n e i s m a d e w i t h o u t d y e s , p a r a b e n s , p h t h a l

nationwide, both online and in stores, including Amazon and www method-

foaming dish spray will be available e

stores, alongside the full method super shine portfolio The 16-ounce liquid and foaming spray dish soaps retail for $4 99 and $6 99, respectively, while the 48-ounce liquid and 16-ounce foaming spray refills are priced at $11 49 and $5.99, respectively. F

Table #608

Continuous Glucose Monitoring on the Rise Among Medicare Advantage Members with Type 2 Diabetes

A new study published in the current issue of the Journal of Managed Care & Specialty Pharmacy (JMCP) – conducte d b y a H u m a n a H e a l t h c a r

Research team and Dr Joseph S

increase in the use of continuous glucose monitors (CGMs) among M

with type 2 diabetes from 2021 to 2023

The study also compared the demographic and clinical characteristics of members with type 2 d i a b e t e s w h

C G M s

h those who did not in 2023, finding t h a t t h e C G M u s

n h a d more complex health problems than those who did not C G M s r e p r e s e n t a m a j o r advancement over traditional fingerstick glucose monitoring methods, providing real-time, continuous blood glucose data that supports more effective management of dangerous highs and lows and reduces the burden of daily monitoring Yet, clinicians still have incomplete information about which patients use these devices and what barriers may exist for those not currently using them.

Additional key findings include:

• T h e p r o p o r t i o n o f M e d i c a r e Advantage members with type 2 diabetes who use insulin and continuous

because, until now, there has been limited information about the use of cont i n u o u s

Medicare Advantage members – a population in which diabetes and the management of multiple health conditions are common,” said Dr. Mark Mugavin, Medical Director at Humana. “These insights help us identify which patients may benefit most from CGMs, including those who do not visit the doctor f r e q u e n t l y , a n d guide our strategies for reaching and supp o r t i n g t h o s e w h o n

glucose monitors increased from fewer than 2 in 100 in January 2021 to about 1 in 6 by December 2023

• The growth in adoption of CGMs was concurrent with the expansion of Medicare coverage for the devices in 2023

• In the 2023 study group, patients who had an endocrinology visit during the year were more than four times as likely to use a CGM device.

As one of the first studies to exami n e C G M u s e i n t h i s p o p u l a t i o n , i t u n d e

u r t h e r research to understand clinical outcomes and to identify which patients benefit most as access expands

RIS Rx (Cont’d. from p. 11)

PBM policies such as maximizers and accumulators, payer policies, pharmacy transactions and patient eligibility

r u l e s c a n c r e a

b l i n d s p o t s t h a t allow billions of dollars intended for patient affordability to be diverted or misapplied

RIS Rx’s platform integrates into existing affordability and patient support ecosystems to provide real-time intervention, monitoring and analytics – before a patient’s first prescription fill Through real-time patient segmentation and program verification, the company helps manufacturers ensure that affordability dollars are directed to the appropriate patients and programs at the moment they are needed.

“ P h a r m a

r s are increasingly realizing that GTN is not just an accounting exercise – it’s an o p e r a t i o n

c

• The analysis found that patients with fewer interactions with the health care system, as well as those in the oldest age group, were less likely to use CGMs

“ T h i s r e s e a r c h i s s i g n i f i c a n t

l y impacts patient access and brand performance,” said Gerard Rivera, Chief Executive Officer and Co-founder of RIS Rx. “Our mission is to bring integrity, v

process so manufacturers can ensure the support they allocate for patients actually reaches those patients ”

Founded by pharmacists, RIS Rx c o m b i n e s c l i n i c a l e x p e r t i s e w i t h advanced analytics to identify, prevent a n d q u a n t i f y G T N l e a k a g e a c r o s s affordability programs The company’s solutions bolt on seamlessly with existing copay vendors and hub providers, enabling rapid deployment with no disruption to patients or established workflows

To date, RIS Rx has helped pharmaceutical manufacturers generate more than $1 billion in annual savings across brands and programs.

“Gross-to-Net has historically been managed through retrospective analysis and periodic audits,” said Stephen H o m , C o - f o u n d e r , E x e c u t i v e V i c e President and Chief Operating Officer of RIS Rx “GTN Revenue Protection introduces a proactive model – one that enables manufacturers to identify a n d p r e v e n t l e a k a g e i n r e a l t i m e , before those dollars are lost.”

Ultimately, this work

improve health out-

that more members

management tools.”

“ C G M

important new tech-

“Characterizing trends in uptake and use helps us better understand the impact of Medicare coverage decisions o

allows us to identify which patient popu l a

e same access to this new technology as others ”

In 2026, most individuals with a Humana Medicare Advantage plan can obtain a CGM at no out-of-pocket cost, as these devices will be fully covered by their plan F

www jmcp org

with real-time visibility into affordability program performance, continuous reporting and compliance assurance, h e l p i n g

intended for patient support is used exactly as intended

About RIS Rx

RIS Rx is a healthcare technology company delivering real-time gross-to-net (GTN) revenue protection for the world’s leading pharmaceutical manufacturers Through proprietary software, real-time analytics and pharmacist-led expertise, RIS Rx helps clients optimize operations, eliminate leakage and ensure that financial assistance reaches the patients who need it most. The company has protected more than $1 billion in annual revenue for its customers Founded in 2020 and headquartered in Irvine, California, RIS Rx serves leading pharmaceutical manufacturers across a growing portfolio of drug brands F o

www.risrx.com.

LGM Pharma Expands U.S. Manufacturing

LGM Pharma, a leading provider of tailored API sourcing, contract analytical testing and CDMO services for the full drug product lifecycle, announced the s e c o n d p h a s e o f i t s C D M O g r o w t h strategy, committing an additional $9 million to its facilities in Rosenberg, Texas and Colorado Springs, Colorado The investment follows the company’s p r e v i o u s l y a n n o u n c e d $ 6 m i l l i o n expansion in Rosenberg in 2025 and is d e s i g n e d t o i n c r e a s e c o m m e r c i a l capacity, expand R&D capabilities and support continued demand for U.S.based drug product manufacturing

The Texas facility enhancements i n c l u d e a $ 4 m i l l i o n i n v e s t m e n t t o expand commercial-scale manufacturing suites for suppositories in response

t o i n c r e a s i n g c u s t o m e r a n d m a r k e t demand, including growth in women’s

h e a l t h p r o d u c t s . T h e u p g r a d e s a l s o expand R&D capabilities to support formulation and scale-up for suppositories, solutions, suspensions and semisolids The Rosenberg site will remain fully operational throughout construction, with upgrades already underway

In Colorado Springs, LGM Pharma will invest $5 million to expand commercial manufacturing capacity for

EmpiRx Health (Cont’d from p 1)

benefits management (PBM) companies The irrefutable fact is that the business practices of these large PBMs pose an existential threat to pharmacy chains of all types and sizes As such, it is kind of “insane” that those pharmacy organizations continue to use these PBMs to manage the pharmacy benefits for their own employees

An excellent front-page article in the New York Times brought these concerns into even sharper focus.

H e r e ’ s h o w t h e N Y T i m e s described the situation:

“P B M s frequently pay the pharmacies at rates that do not cover the

b a r r i e r b e t w e e n s a l o n - g r a d e r e s u l t s and affordable hair care products The n e w S u a v e S u l f a t e - F r e e H a i r C a r e C o l l e c t i o n p r o v e s t h a t c u t t i n g - e d g e innovation is within reach for everyone

Every product in the lineup is crafted without sulfates, parabens, mineral oil or phthalates, making them safe for color-treated hair and gentle on the scalp. The ingredients reflect a brandwide commitment to high-quality care, w h i c h a l s o e x t e n d s t o t h e n e w

Exfoliating Body Wash collection By incorporating celebrated powerhouses like glycolic and hyaluronic acid, Suave is bridging the gap between advanced hair science and the everyday routine

niche, high-value oral solid dose (OSD) products, including orally disintegrating tablets (ODTs) The facility has served as the company’s center of excellence for OSD development. The expansion, planned for completion this year, will support growing demand for domestic manufacturing In 2024, the global OSD CDMO market was valued at $43 65 billion, with North America accounting for approximately 40 5% of global OSD pharmaceutical manufacturing activity

“These multi-site investments totaling $15 million reflect our continued commitment to strengthening pharmaceutical supply chains in the United States,” said Prasad Raje, Chief Executive Officer of LGM Pharma “Today’s pharma companies need partners that are both resilient and integrated across the full product lifecycle. By reinforcing domestic drug product manufacturing at the downstream end of the supply chain, closer to end markets, and leveraging our global API sourcing capabilities upstream, we create a balanced end-to-end model This gives customers greater control and visibility as they move products from development to commercialization ”

Earlier in the supply chain, at the drug substance stage, LGM Pharma sup-

costs of the drugs, according to more than 100 pharmacists around the country and dozens of examples of insurance paperwork and legal documents

… In every state, The Times identified at least one example since 2022 in

ports 505(b)(2), NDA, and ANDA programs through a global network of more than 220 pre-qualified API manufacturers By combining global drug substance sourcing with expanded U S finished dose development and manufacturing, the company provides integrated support across the full drug product lifecycle.

Hamilton Lenox, Chief Commercial Officer of LGM Pharma, said the company’s prior Rosenberg upgrades from Phase I of the expansion, including implementation of enhanced track-andtrace serialization systems and increased production volumes, are now complete. “We are executing this next phase of expansion while keeping both facilities fully operational,” Lenox said “Our teams are experienced in managing complex upgrades without sacrificing quality or disrupting customer supply, which remain our top operational priorities Rather than overextending in a single phase, we are executing these enhancements incrementally to expand capabilities and capacity while ensuring operational continuity This approach allows us to strengthen infrastructure, support customer growth, and scale in response to market demand ”

About

LGM Pharma

LGM Pharma is a leading contract development and manufacturing organization

still turn to them when choosing a PBM partner

(CDMO) providing comprehensive Active Pharmaceutical Ingredient (API) sourcing, drug product CDMO services and contract analytical testing services to the pharmaceutical, biotechnology and compounding pharmacy industries LGM Pharma assists clients in managing all phases of the drug product development process, from API sourcing through to drug product commercialization LGM Pharma’s extensive global network of qualified API partners enables clients to optimize supply chain management and distribution Services include API sourcing and procurement, formulation development, drug product manufacturing, analytical method development, method and process validation, ANDA/NDA submission, stability studies, and raw material and finished product testing and packaging LGM Pharma is committed to quality and has a long-established positive regulatory track record, providing expert regulatory and market intelligence services to its clients. The company is focused on customer service and customized solutions, providing clients with a comprehensive U S -based manufacturing solution that reduces risk, increases efficiency and accelerates the path to commercialization

lgmpharma com

become routine ”

None of the examples in the Times article will come as a surprise. However, given the growing amount of evidence

t

largest PBMs are essentially misaligned with those of the pharmacy industry, it begs the question why so many chains

Advanced Systems for Visible Results

The collection uses high-quality ingredients to maintain the integrity of the hair fiber, while delivering softness and shine without heaviness. The innovation is categorized into two benefit-driven assortments:

Hydra Gloss: Glossy Shine + Frizz Reduction

To explore these questions further and to create better PBM solutions for the industry, EmpiRx Health has been a c t i v e l y p a r t n e r i n g w i t h i n d u s t r y thought leaders, key legislators, regulators and forward-thinking pharmacy chains on a framework for real change and transparency There is a growing consensus that it just does not make sense anymore for pharmacy organizations to award their business to PBMs who are working against their best interests, and those of their key stakeholders

In 2025, we launched AllyRx, the first-ever national pharmacy care net-

$5 97)

• 5-Min Hair Gloss: A standout rinseoff glaze that seals the hair surface in just five minutes for a professional, high-shine finish ($5.97).

Moisture Repair:

Weightless Hydration + Softness

D e s i g n e d f o r d r y , d e p l e t e d s t r a n d s , these products feature Hyaluronic Acid to attract moisture and Aloe Vera to restore manageability

work built specifically for pharmacy and grocery retailers We also launched t h e P h a r m a c y A l l i e s

Healthcare (PATH) Coalition, a national coalition established to help protect and empower community pharmacies and pharmacists

Together, these initiatives represent an exciting and innovative new pharmacy care model and vision that delivers strongly on the true promise

Umbrella #238

parched hair ($5 97)

Accessibility Meets Excellence T h e 2

commitment to making quality accessible By keeping every item in the collection at or under the $6 mark, the brand i s e n s

ingredient-led hair care is an achievable reality for all consumers

The Suave Sulfate-Free Collection is available at Walmart, Family Dollar, Kroger, Meijer and other leading retailers

18-

formulas gently cleanse and smooth the cuticle to reveal luminous shine (Available in 12 6-ounce for $3

• S h a m p o o & C o n d i t i o n e r : T h e s e formulas detangle and boost hydration with a weightless feel, ensuring hair r e m a i n s s o f t r a t h e r t h a n w e i g h e d d o w n ( A v a i l a b l e i n 1 2 6 - o u n c e f o r $3 97, 18-ounce for $4 97 and 28-ounce for $5 97)

• Deep Moisture Mask: An intensive

Suave (Cont’d from p 1)

(Cont’d from p 1)

T h e s e n e w m a g n e s i u m - b a s e d gummies combine trusted science with an easy-to-integrate solution for daily gut care Consumers chew three gummies daily with a glass of water. Each gummy contains 100 mg of magnes i u m . M a g n e s i u m h e l p s k e e p y o u r digestive system running smoothly by w o r k i

hydrate and soften stool* The results

users reporting feeling more comfortable, and 88% of users noting their bowel movements felt easier to pass*† . Dulcolax gummies are available in

data. We recently advanced our Liquid AI™ technology to help organizations shift from hindsight to foresight at an u n p r e c e d e n t e d s c a l e E n g i n e e r e d specifically for the complexities of retail a n d c o n s u m e r b e h a v i o r , L i q u i d A I delivers fast, context-rich intelligence exactly when you need it.

We bring this power directly to your team through two breakthrough experiences: the Emiri™ agent and the Brainwave™ solution

Democratizing Intelligence with the Emiri Agent

Most retail organizations rely heavily

Sally Hansen (Cont’d from p 1)

more fun) thanks to Sally Hansen – you can literally create salon-quality vibes from the comfort of your home

Originally introduced more than a decade ago and long celebrated for redefining the at-home gel manicure, Sally Hansen’s Miracle Gel has received an upgrade to its fan-favorite formula With formula updates available in their new Super Charged Pink shade range,

Rivera (Cont’d from p 1)

r e g u l a t o r y r e q u i r e m e n t s a r e b e i n g applied correctly at the claim level

The brief, titled, “Reform does not e n f o r c e i t s e l f : W h y P B

i

v e

i c a t i o n g a p requires a new operating discipline: c o n t i n u o u s o v e r s i g h t o f p h a r m a c y claims

The issue brief details how reform has shifted the pharmacy benefit landscape in four key areas: PBM compen-

M&M’S (Cont’d. from p. 4)

available in a 5.5-ounce Small Stand-Up Pouch on www mms com, with nationwide availability at retailers beginning in January 2026 This resealable candy bag of crunchy and airy treats makes snacking easier to take on the go and to save for later More sizes will follow later in the year. For more details on M & M ’ S C a r a m e l P O P ’ d , v i s i t www mms com and follow M&M’S on Facebook, X, TikTok and Instagram

F o r m o r

or stop by Space #21

on a few analytical leaders to translate data for the entire business. This creates bottlenecks. The Emiri agent functions as your digital teammate, combining sophisticated analysis with the simplicity of natural language

W i t h E m i r i , c o m p l e x

n

l y s i s becomes a simple conversation Store managers, category buyers and executives can ask questions and receive immediate, reliable answers. You no longer need to wait in a queue for a c u s t

essential insights, Emiri frees up your data experts to focus on advanced, strategic planning rather than routine data pulls.

Miracle Gel has been upgraded with Color Grip complex for polish adhesion

The brand has also launched two new Miracle Gel topcoats, Miracle Gel Super Shiny Shield Topcoat and Miracle Gel Super Volume Builder Topcoat, with t h e n e w u p d a t e d r a n g e p r o v i d i n g superior quality, longer wear (up to 16 days!) and effortless application

New shades include Tough Love, Boss Babe, Fog-et Me Not, Blush Crush, Berry Best Effort, Work Hard, Play Pink,

s sthrough; disclosure and audit expectations are expanding under the proposed DOL rule; regulatory and political focus on PBM practices has become s u s t a i n e d r a t h e r t h a n e p i s o

state-level requirements continue to stack across licensure, spread pricing and network rules Each of these shifts must ultimately be reflected in contracts, benefit designs and claims conf

opportunities for errors that traditional

AOM Infusion (Cont’d from p 4)

QIVIGY is a ready-to-use, sterile, non-pyrogenic liquid solution of human immune globulin (IgG) for IV administration. It supplies a broad spectrum of antibodies against bacterial and viral agents to support patients with Primary Immunodeficiency Disorders (PID)

Kedrion selected AOM as a distribution partner for its deep expertise in

c a l model. AOM’s recognition as one of the first specialty providers in the nation to earn the Distinction in Ig Therapy from

free from synthetic dyes

This innovation positions Dulcolax as more than just the trusted leader in laxatives It is now a player in the daily gut wellness space If you’re looking for daily gut support*, Dulcolax Gummies are designed to seamlessly integrate into your daily routine Take the first s t e p

Widening

requires deep, manual analysis across hundreds of brands, categories and store locations This resource-intensive process forces tough trade-offs, often leaving smaller parts of your portfolio behind.

The Brainwave solution changes this equation by delivering AI-powered data storytelling at scale It automates complex processes and rapidly analyzes vast datasets, ensuring every part of your business gets equal attention B r a i n w a v e m u l t i p

bandwidth, delivering clear narratives

Go Hard or Glow Home and Unstop-purple Each shade delivers longer wear, stronger adhesion and high shine with zero UV light needed The upgraded formula + Color Grip complex provides salon-quality results and up to 16 days of stunning wear when used as a two-step system with the topcoats with reapplication of the topcoat on day seven

The new Miracle Gel Super Shiny S h i e l d T o p c o a t a n d S u p e r V o l u m e Builder Topcoat offer 20x more light-

periodic audits are not designed to catch in real time

“The conversation has shifted from whether PBMs should be more transparent to whether that transparency is

Rivera. “Health plans that treat reform as a reason to ease up on oversight will still be accountable for every dollar that runs through their pharmacy bene

value, not just compliance

the ACHC and IgNS further demons t r a t e s i t s c o m m i t m e n t t o

comes-driven care.

“ W e ’ r e p r o u d t o m a k e Q I V I G Y available nationwide, offering a reliable new option for patients in need of IVIG t h e r a p y , ” s a i d B o b R o s s i l l i , C h i e f C o m m e r c i a l O f f i c e r o f K e d r i o n

“Through our long-standing relationship with AOM Infusion, we aim to r e a c h p a t i e n t s w h e r e t h e y a r e a n d ensure access to the therapies they need most. By combining our expertise and resources, we can bring QIVIGY to more communities and help support

out with Dulcolax*† F o r m o r e i n f o r m a t i

dulcolax com

*These statements have not been evaluated by the Food and Drug Administration This product is not intended to diagnose, treat, cure or prevent any disease †Based on a two-week, in-home use test with 203 adults

around a single, unified view of market dynamics.

Move From Keeping Up to Leading the Way

d durability, 35% more shine boosters for a lasting mirror-like finish and 41% m o r e p l u m p i n g a g e n t s f o r a f

e r , more magnified mani. When paired together, Miracle Gel provides extra dimension, shine and trend-driven finishes for a mani that’s custom to you

For more information, go to www sally hansen com or stop by Mezzanine #15

Rivera’s continuous monitoring platform evaluates 100% of pharmacy claims against benefit design, contract terms and regulatory requirements using more than 750 proprietary algorithms Unlike traditional retrospective audits, which typically review a sample of claims months after a plan year closes, Rivera’s approach surfaces discrepancies on an ongoing basis, enabling dollar recovery and preventing repeat errors

riverarx com

patients and families ” “ T h i s p a r t n e r s h i p w i t h K e d r i o n r e f l e c t s o u r s h a r e d c o m m i t m e n t t o i m p r o v i n g a c c e s s t o l i f e - e n h a n c i n g therapies for patients with complex immune disorders,” says Karmen Stowe, Vice President of Trade Relations & Supply Chain “By expanding our Ig portfolio with QIVIGY, we are strengthening our ability to support providers with reliable therapy options and helping patients receive high-quality infusion care that best supports their lives.”

F o r m o r e i n f o r m a t i o n , g o t o w w w qivigy com/hcp

Liquid AI (Cont’d. from p. 1)
the Lens with the Brainwave Solution

Turn static files into dynamic content formats.

Create a flipbook
Chain Drugstore Daily @ NACDS AM • April 21, 2026 by OserCommunicationsGroup - Issuu